Literature DB >> 33244561

The Prevalence and Clinical Characteristics of Essential Tremor in Elderly Chineses: A Population-Based Study.

H Sun1, F Sun, X-Q Zhang, X-H Fang, P Chan.   

Abstract

OBJECTIVES: To investigate the prevalence and the clinical feature of essential tremor (ET) in a community cohort in Beijing.
METHODS: Using a door-to-door, two-phase approach, we investigated 2,835 residents aged ≥55 years old from rural, urban, and mountain areas.
RESULTS: The prevalence rate of ET was 4.29%, 2.85%, and 2.29% in rural, urban, and mountain areas, respectively. The overall age- and sex-adjusted prevalence was 3.29%. Among those aged ≥75 years, the prevalence rate in the urban area was higher than those in the rural and mountain areas. The prevalence rate increased with age, and the prevalence was higher among men (6.0%) than among women (3.6%). There was a correlation of ET prevalence with age, sex, and habitation area, but not with alcohol, tea drinking, and occupation. Women (25%) with ET were more likely to have head tremor than men (16.9%).
CONCLUSIONS: The ET prevalence in the elderly of Beijing was 3.29% which is higher in the urban area and in men.

Entities:  

Keywords:  Essential tremor; epidemiology; gender; population-based; prevalence

Mesh:

Year:  2020        PMID: 33244561     DOI: 10.1007/s12603-020-1472-7

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  2 in total

1.  Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor: A 2-Year Outcome Study of Chinese People.

Authors:  Peihan Wu; Wei Lin; Kun Hong Li; Hui-Chin Lai; Ming-Tsung Lee; Kevin Wen-Kai Tsai; Pai-Yi Chiu; Wei-Chieh Chang; Cheng-Yu Wei; Takaomi Taira
Journal:  Front Aging Neurosci       Date:  2021-07-14       Impact factor: 5.750

2.  How Common is Essential Tremor? Update on the Worldwide Prevalence of Essential Tremor.

Authors:  Elan D Louis; Morgan McCreary
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.